Blog
Webinar Recap: The 3 Questions to Consider In Your New Product Launch
If you haven’t had a chance to watch the on-demand webinar, “Top 3 Questions Facing New Launches,” but are curious about where to start with the pharmaceutical commercialization process, we’re giving you a recap of the highlights. [...]
Public Policy Strategy Helps Realize Clear Access Path for Patients
We’ve entered a new era in the U.S. healthcare system with the passage of the Inflation Reduction Act’s (IRA) landmark policy changes. And whether you are an emerging manufacturer bringing your first drug to market or more seasoned [...]
Two Labs’ New Medical Communications Service was Built with Emerging Pharma in Mind
Given the complexities that an emerging manufacturer is managing when developing a new product for launch, it might sound like medical communications is just one more thing on the list. But this couldn't be further from the truth. [...]
Cell & Gene Therapies: How the Industry is Innovating & What Emerging Manufacturers Need to Know
Thousands of rare diseases affect hundreds of millions of people globally, and hope for treatment is on the rise in the form of cell and gene therapies. While only 9 cell and gene therapies are currently FDA-approved in [...]
Case Study: Mock Launch Support
NEED A pharma client came to Two Labs for patient services mock launch testing prior to their first product commercialization in the U.S. market. The goal was to ensure successful product launch upon [...]
Case Study: Post Launch Support
NEED A biopharma client needed post-launch support for a patient services program for their breakthrough therapy and orphan drug designated immune-oncology product. Their external patient services model included a designated third-party partner that [...]